Clinical and pharmacological implications for a high rate of unrecognized SARS-CoV-2 infected psychiatric patients

Brain Behav Immun. 2024 Feb:116:124-125. doi: 10.1016/j.bbi.2023.12.012. Epub 2023 Dec 7.

Authors

Benedetta Vai¹, Mario Gennaro Mazza²

Affiliations

¹ Psychiatry and Clinical Psychobiology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy; University Vita-Salute San Raffaele, Milano, Italy. Electronic address: vai.benedetta@hsr.it.
² Psychiatry and Clinical Psychobiology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milano, Italy; University Vita-Salute San Raffaele, Milano, Italy.

PMID: 38070617
DOI: 10.1016/j.bbi.2023.12.012

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Humans
Risk Factors
SARS-CoV-2*